Use our pre-submission checklist
Avoid common mistakes on your manuscript.
1 Correction to: American Journal of Cardiovascular Drugs (2020) 20:81–103 https://doi.org/10.1007/s40256-019-00359-z
The wrong Supplementary file was originally published with this article; it has now been replaced with the correct file.
The original article has been corrected
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Blin, P., Dureau-Pournin, C., Bénichou, J. et al. Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS. Am J Cardiovasc Drugs 22, 111 (2022). https://doi.org/10.1007/s40256-021-00517-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40256-021-00517-2